`Attachments:
`
`Celgene - Confidential Settlement Communication
`IPR Petition 6045501.pdf; Declaration of Matthew Davis 6351720 Anticipation.pdf; Declaration
`of Matthew Davis 6045501.pdf; Declaration of Matthew Davis 6315720 Obviousness.pdf; IPR
`Petition 6315720 Anticipation.pdf; IPR Petition 6315720 Obviousness.pdf; 999-1[2014-07-15
`13-35-53].pdf
`
`Marc Fenster <mfenster@raklaw.com>
`aminsogna@jonesday.com,
`Marc Fenster <mfenster@raklaw.com>
`07/15/2014 02:03 PM
`Celgene - Confidential Settlement Communication
`
`From:
`To:
`Cc:
`Date:
`Subject:
`
`
`
`Anthony,
`
`We represent the Initiative for Responsibility in Drug Pricing ("IRDP"). IRDP's mission is to improve
`America's access to low cost generic pharmaceuticals. Additional information on IRDP can be found at
`www.irdp-patents.net).
`
`Please find attached three draft Petitions for Inter Partes Review for US Patent Nos. 6,045,501 and
`6,315,720. Also attached is a chart showing the patent family relationships for the '501 and '720 patents.
`
`IRDP intends to file the attached IPRs this Friday, July 18. Please give me a call if you have any questions or
`would like to discuss the attached.
`
`Regards,
`
`Marc
`
`
`
`Marc Fenster
`Russ, August & Kabat
`12424 Wilshire Blvd, 12th Floor
`Los Angeles, CA 90025
`310-979-8278 (direct)
`310-826-7474 (main)
`mfenster@raklaw.com
`
`
`
`==========
`This e-mail (including any attachments) may contain information that is private, confidential, or protected by attorney-client
`or other privilege. If you received this e-mail in error, please delete it from your system without copying it and notify
`
`1
`
`Page 1 of 2
`
`CELGENE EXHIBIT 2042
`Coalition for Affordable Drugs VI LLC (Petitioner) v. Celgene Corporation (Patent Owner)
`Case IPR2015-01102
`
`
`
`sender by reply e-mail, so that our records can be corrected.
`==========
`
`2
`
`Page 2 of 2